It has been reported that S100A2 was highly expressed in non-small cell lung cancer, esophageal squamous cell carcinoma, laryngeal squamous cell carcinoma, ovarian serous papillary carcinomas, as well as gastric cancer. This evidence concerns the gene S100A2 and esophageal squamous cell carcinoma.